Statement Of Cash Flows [Abstract]

Biotage - Filing #702086

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations before changes in working capital
332,000,000 SEK
2 70 SEK
Increase (decrease) in working capital
21,000,000 SEK
9,000,000 SEK
Adjustments for decrease (increase) in trade and other receivables
16,000,000 SEK
9,000,000 SEK
Adjustments for increase (decrease) in trade and other payables
60,000,000 SEK
23,000,000 SEK
Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss
75,000,000 SEK
74,000,000 SEK
Income taxes paid, classified as operating activities
1 6 SEK
1 5 SEK
Cash flows from (used in) financing activities [abstract]
Dividends paid to equity holders of parent, classified as financing activities
98,000,000 SEK
- SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.